JAZZ vs PFS · P/E 1988, rev $2.28B vs P/E 16, rev $40.3M
Jazz Pharmaceuticals PLC (JAZZ) versus Provident Financial Services Inc (PFS) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Provident Financial Services Inc (PFS) is a banks - regional company listed on US.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported PFS revenue for 2026-06-30 was $40.3M. Net income was $157.6M. Revenue was up 95.3% from 2026-03-31 to 2026-06-30. PFS currently screens at market cap $2.31B and trailing P/E 16.0.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. PFS currently screens at market cap $2.31B and trailing P/E 16.0.
Not investment advice. Open the JAZZ and PFS stock pages for the full models.
Not investment advice.